Putnam Investments LLC Cyma Bay Therapeutics, Inc. Transaction History

Putnam Investments LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$10.66 - $14.38 $1.04 Million - $1.41 Million	-98,025 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$9.0 - $15.16 $271,710 - $457,680	-30,190 Reduced 23.55%	98,025 $1.27 Million
Q4 2017 Feb 14, 2018	BUY	$7.67 - $9.31 $983,409 - $1.19 Million	128,215	128,215 $1.18 Million

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Putnam Investments LLC with notifications on news.